Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-02-02 @ 11:48 AM
Study NCT ID:
NCT00383292
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2006-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tasisulam in Treating Participants With Malignant Melanoma
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-29
First Submit QC Date:
None
Study First Post Date:
2006-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-17
Results First Submit QC Date:
None
Results First Post Date:
2018-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-02-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-05-04
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL